19h
Zacks.com on MSNVertex to Report Q4 Earnings: What's in Store for the Stock?Vertex, Inc. VERX is scheduled to report fourth-quarter 2024 results before market open on Feb. 27. Find the latest EPS ...
Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 5.86% on an annualized basis producing an average annual return of 17.7%. Currently, Vertex Pharmaceuticals has a ...
Read about a $100 million single-award IDIQ contract awarded by the FBI to Vertex Aerospace for aviation maintenance support ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 ...
One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's ...
"If we do our jobs right, and you come back a year from now, this place is going to be a buzzing hive" -- Vertex Executive ...
Vertex Flare is an online crypto trading platform designed using the latest technologies like artificial intelligence and ...
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...
On its pricing page, the tech giant has now detailed what it will charge its Vertex AI users to access its video generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results